IL165786A0 - Ibuprofen suspension - Google Patents

Ibuprofen suspension

Info

Publication number
IL165786A0
IL165786A0 IL16578604A IL16578604A IL165786A0 IL 165786 A0 IL165786 A0 IL 165786A0 IL 16578604 A IL16578604 A IL 16578604A IL 16578604 A IL16578604 A IL 16578604A IL 165786 A0 IL165786 A0 IL 165786A0
Authority
IL
Israel
Prior art keywords
suspension
ibuprofen suspension
ibuprofen
pharmaceutically acceptable
effective amount
Prior art date
Application number
IL16578604A
Other languages
English (en)
Original Assignee
Taro Pharmaceuticals Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceuticals Usa Inc filed Critical Taro Pharmaceuticals Usa Inc
Publication of IL165786A0 publication Critical patent/IL165786A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16578604A 2002-06-17 2004-12-15 Ibuprofen suspension IL165786A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38873402P 2002-06-17 2002-06-17
PCT/US2003/018922 WO2003105804A1 (fr) 2002-06-17 2003-06-17 Suspension d'ibuprofene

Publications (1)

Publication Number Publication Date
IL165786A0 true IL165786A0 (en) 2006-01-15

Family

ID=29736532

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16578604A IL165786A0 (en) 2002-06-17 2004-12-15 Ibuprofen suspension

Country Status (10)

Country Link
US (1) US20040258716A1 (fr)
EP (1) EP1513499B1 (fr)
JP (1) JP2005530822A (fr)
CN (2) CN101862292A (fr)
AT (1) ATE541562T1 (fr)
AU (1) AU2003238221A1 (fr)
CA (1) CA2486553C (fr)
ES (1) ES2379464T3 (fr)
IL (1) IL165786A0 (fr)
WO (1) WO2003105804A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758877B2 (en) * 2004-02-05 2010-07-20 Taro Pharmaceuticals U.S.A., Inc. Stable loratadine spill resistant formulation
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8021682B2 (en) * 2004-08-13 2011-09-20 Gallipot, Inc. Palatable suspending vehicle for pharmaceutical ingredients
US7799331B2 (en) 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090023638A1 (en) * 2006-02-06 2009-01-22 Taro Pharmaceuticals North American, Inc. Spill resistant antibiotic formulations
JP5226661B2 (ja) * 2006-04-06 2013-07-03 ターロ ファーマシューティカルズ ノース アメリカ インコーポレイテッド 親水コロイド重合体を含む新規な耐流出性製剤
US8048383B2 (en) * 2006-04-20 2011-11-01 Velocys, Inc. Process for treating and/or forming a non-Newtonian fluid using microchannel process technology
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
FR2922443B1 (fr) * 2007-10-17 2012-11-09 Georgia Pacific France Composition cosmetique destinee a impregner un article de nettoyage et/ou de soin de la peau
ES2729925T3 (es) 2007-11-13 2019-11-07 Meritage Pharma Inc Composiciones de corticosteroides
WO2010030821A2 (fr) * 2008-09-10 2010-03-18 Biochemics, Inc. Ibuprofène destiné à être administré de manière topique
CA2702604C (fr) 2008-09-22 2013-12-03 Biochemics, Inc. Administration transdermique de medicaments employant un osmolyte et un agent vasoactif
CN102448499A (zh) * 2009-04-27 2012-05-09 药效学应用实验室股份有限公司 赖氨酸布洛芬口服混悬剂
EP2440210A4 (fr) 2009-06-12 2014-01-29 Meritage Pharma Inc Procédés de traitement de troubles gastro-intestinaux
KR101683293B1 (ko) * 2009-06-29 2016-12-06 라이온 가부시키가이샤 경구용 조성물
WO2011031176A1 (fr) * 2009-09-10 2011-03-17 Bial - Portela & C.A., S.A. Formulations de suspension orales d’acétate d’eslicarbazépine
BR112015005882A2 (pt) * 2012-09-18 2017-07-04 Mcneil Ppc Inc formulações farmacêuticas em suspensão compreendendo partículas derivadas do ácido propiônico com baixo ponto de fusão
JP6221644B2 (ja) * 2012-11-09 2017-11-01 大正製薬株式会社 経口用組成物
US11458096B2 (en) 2014-04-09 2022-10-04 Pulse Pharmaceuticals Pvt. Ltd. Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
JP2018516279A (ja) * 2015-05-29 2018-06-21 コーダドース・インコーポレーテッド 経口投与用のセレコキシブの液状配合物
CN106397181B (zh) * 2016-09-08 2019-01-01 山东理工大学 一种通过添加十二烷基硫酸钠自水溶液中制备长针状布洛芬晶体的方法
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921884A (en) * 1957-09-30 1960-01-19 Sterling Drug Inc Pharmaceutical compositions
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
JPS63218247A (ja) * 1987-03-06 1988-09-12 Yoshiaki Kawashima 高機能懸濁液
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5006360B1 (en) * 1988-06-27 1992-04-28 Low calorie fat substitute compositions resistant to laxative side effect
US4918103A (en) * 1988-07-25 1990-04-17 Formulations Development Labs Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
JP2814138B2 (ja) * 1990-07-23 1998-10-22 エスエス製薬株式会社 懸濁シロップ剤
US5137183A (en) * 1990-08-02 1992-08-11 Mikulec Timothy L Compressible feeding apparatus
JP3005292B2 (ja) * 1990-08-02 2000-01-31 カイロン コーポレイション 単純ヘルペスウィルスのｖｐ１６のワクチン
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
IT1264857B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
JPH08333245A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
AU717764B2 (en) * 1996-05-02 2000-03-30 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
AU6855198A (en) * 1997-04-21 1998-11-13 Taisho Pharmaceutical Co., Ltd. Ibuprofen suspension preparations
US5840768A (en) * 1997-06-04 1998-11-24 Fmc Corporation MCC: alginate pharmaceutical suspensions
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
BR0009557A (pt) * 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
US6557732B2 (en) * 2000-07-19 2003-05-06 The Procter & Gamble Company Detergent pack
JP2001294528A (ja) * 2001-06-06 2001-10-23 Kobayashi Kako Kk アシクロビル懸濁シロップ剤

Also Published As

Publication number Publication date
ATE541562T1 (de) 2012-02-15
ES2379464T3 (es) 2012-04-26
US20040258716A1 (en) 2004-12-23
CN101862292A (zh) 2010-10-20
JP2005530822A (ja) 2005-10-13
CA2486553A1 (fr) 2003-12-24
AU2003238221A1 (en) 2003-12-31
WO2003105804A1 (fr) 2003-12-24
EP1513499B1 (fr) 2012-01-18
CA2486553C (fr) 2012-01-10
CN1655762B (zh) 2010-05-26
EP1513499A1 (fr) 2005-03-16
CN1655762A (zh) 2005-08-17

Similar Documents

Publication Publication Date Title
IL165786A0 (en) Ibuprofen suspension
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
DK1169024T3 (da) Prægelatineret stivelse i en formulering med kontrolleret frigivelse
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
WO2000041681A3 (fr) FORMULATIONS DE MEDICAMENTS CONTENANT UN OPIOIDE ET UN α-AGONISTE
EP1589947B8 (fr) Formulation pharmaceutique ayant un agent actif insoluble
EP0966966A3 (fr) Forme posologique de néfadozone
HK1096034A1 (en) A solid dosage form comprising a fibrate
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
BG108516A (en) Pharmaceutical formulation
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
WO2002024203A3 (fr) Formulation à administrer oralement à libération contrôlée
WO2002011694A3 (fr) Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses
PL346764A1 (en) New oral formulation for 5-ht4
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
MY145885A (en) Controlled release formulations for oral administration